|
⚲
|
| Keyboard |
| John Mulligan | |
|---|---|
| Firm | |
| Address | c/o Bonum Therapeutics, Inc 1616 Eastlake Avenue East, Suite 400 Seattle, WA 98102 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Bonum Therapeutics Inc | 021-465970 | Executive Officer | 45.0 M of 93.0 M |
||
| Bonum Therapeutics Inc | 021-426281 | Executive Officer | 1.2 M of 3.6 M |
||
| Good Therapeutics Inc | 021-426282 | Executive Officer | 8.8 M of 26.4 M |
||
| Good Therapeutics Inc | 021-326349 | Executive Officer | 22.3 M of 22.3 M |
||
| Glycostasis Inc | 021-241544 | Executive Officer | 0.1 M of 2.7 M |
||